Introduction
Approximately 63 110 people are living with HIV in Canada. 1, 2 Despite that people from HIVendemic countries, including most subSaharan African (SSA) coun tries, are overrepresented in national HIV surveillance data, 1,2 very little is known about the experiences of SSA immigrants living with HIV in Canada. Although sev eral populationbased studies have been conducted in central Canada, information about SSA immigrants living with HIV in western Canada is limited, despite an increasing number of new cases of HIV among immigrants from countries where HIV is endemic. 3 Most immigrants must complete an immi gration medical examination (IME) as part of the application process to immigrate to Canada. Mandatory HIV screening was introduced in 2002. All IMEs are con ducted by panel physicians designated by the Canadian federal government. Panel physicians are practising physicians living in Canada or nonCanadian nationals liv ing in other countries. 4 In Goffman's seminal work, 5 stigma refers to the complex concept of deviance and societal perceptions of people perceived to differ from societal norms. HIVrelated stigma has been conceptualized in differ ent ways in the literature. 6 Internalized stigma is defined as "the acceptance among people living with HIV of negative beliefs and feelings associated with HIV about themselves." 6,p4 Enacted stigma is defined as "acts of discrimination, such as exclusion, or physical or emotional abuse towards an individual's real or perceived identity or membership to a stigmatized group." 7,p.1 Internalized HIV stigma is associated with poor HIV medication adherence, poor engagement in the HIV care cascade and poor health and social outcomes. 813 The immigrant population in Canada may face extraordinary barriers to achieving positive health and social outcomes com pared to the nonimmigrant Canadian population, 14, 15 resulting in health inequal ities. It is especially important to under stand internalized HIV stigma among immigrants living with HIV, as immigra tion policies, migration and settlement experiences may affect their engagement in the HIV care cascade. Very little research exists on immigration applicants' experiences during the IME, HIV stigma, migration, settlement and access to spe cialized health services for HIV. More spe cifically, there is limited research on experiences of stigma during the IME's mandatory HIV screening. Also limited is research on how that stigma influences engagement in the HIV care cascade dur ing migration to and settlement in Canada.
Objectives
Our research question was: How do SSA immigrants living with HIV in a western Canadian province internalize and experi ence HIVrelated stigma encountered dur ing the IME?
The objectives of this exploratory pilot study were (1) to measure HIVrelated stigma among SSA immigrants living with HIV, using the Internalized HIV Stigma Scale (IHSS) 16 ; and (2) to explore how SSA immigrants living with HIV experi enced HIVrelated stigma during the IME.
We examine our study results through the theoretical lens of intersectionality 17 and critical social theory. 18 We gathered insights on how mandatory HIV screening of immi gration applicants, their legal status, stigma and culture influence health and social disparities in this population.
Methods
In this mixedmethod pilot study, we col lected quantitative data including sociode mographic and clinical data as well as data from the IHSS. 16 Qualitative data were collected through semistructured interviews. Using purposive sampling, we collaborated with communitybased orga nizations and HIV clinics to recruit partici pants. Given the exploratory nature of this study, we were not aiming for a sample size with adequate power to detect statis tically significant differences.
We used the following inclusion criteria: 18 years of age or older; a confirmed posi tive diagnosis of HIV; completion of man datory HIV screening as part of the Canadian IME (this applies to immigrants who arrived in Canada after 2002); and ability to understand and speak English. Each interview lasted approximately one hour. An honorarium of $25.00 was pro vided. Offering this small honorarium (66% over the minimum hourly wage in this province) honours the expertise that community members bring, particularly experiential people, and shows the value of people engaged in communitybased research.
Ethics approval was obtained from three universitybased research ethics boards: University of Calgary (REB15-0471), University of Alberta (PR000056579) and the University of Lethbridge (HSRC2015-035).
The IHSS is the first documented multidi mensional measure of internalized HIV related stigma related to treatment and other aspects of the disease among sociodemographically diverse people liv ing with HIV in North America. It is a 28item measure of internalized HIV stigma composed of four subscales (ste reotypes, disclosure of HIV concerns, social relationships and selfacceptance). 16 Because of the small sample size in this pilot study (N = 8), we retained quantita tive data for descriptive analysis only. The qualitative component of this study yielded rich data and is the focus of the findings reported here.
Members of the research team interviewed study participants using a semistructured interview guide. The interview guide included questions on HIV stigma; HIV testing during the immigration process; the experience of stigma; and engagement in the HIV care cascade during the IME, migration and settlement. Interviews were audiorecorded and transcribed verbatim.
We analyzed the qualitative data using approaches described by Corbin and Strauss. 20 Although we did not base this study on a grounded theory research method, the research team analyzed qual itative data in an iterative process of data analysis and data collection. Concepts related to HIV stigma were identified by the researchers working as a team. The concepts were grouped together under broader categories related to HIV stigma and the Canadian (IME) process, and then assessed, through constant comparative analysis, for patterns or themes of similar ities and/or differences. 19, 20 The research team engaged primarily in open coding 19, 20 in analyzing data, with a primary focus on examining events, actions and interactions.
Results

Sample characteristics
HIV in the SSA immigrant community in Canada is a highly stigmatized and sensi tive subject, 21, 22 and the research team anticipated and experienced challenges in recruiting participants from the commu nity. Working with community stakehold ers and collaborators, such as HIV clinics and AIDS service organizations, and as a result of multiple efforts, we were able to recruit eight participants who completed the IHSS survey; seven consented to an in depth individual followup interview with a researcher. The legal status of partici pants varied: some were living in Canada as refugee claimants, some as govern mentassisted refugees and some as per manent residents under sponsorship*. Table 1 summarizes the key characteris tics of participants.
Due to the small sample size (N = 8), quantitative findings were descriptively analyzed to provide contextual informa tion alongside the qualitative findings. Table 2 shows the number of participants who experience stigma "most" or "all of the time" in each IHSS domain. We found that most participants (5/8) had high internalized stigma associated with their positive HIV status in the domain of selfacceptance.
The Immigration Medical Examination process experience of immigrants living with HIV
The following key thematic categories emerged from our qualitative analysis of interview data:
• experiences of HIVrelated emotional distress during the IME;
• varied experiences of HIV testing dur ing the IME;
• inconsistent patterns of linkage to medical care, psychosocial supports; and
• engagement in the HIV care cascade. 
Experiences of HIV-related emotional distress during the IME
Relationship status
In a relationship with one person 4
Not in a relationship 4
Sexual behaviour
I am a man who has sex with women 4 I am a woman who has sex with men 3
Other 1
HIV test was done during Canadian IME
Yes 8
Found out for the first time about HIV-positive status at Canadian IME
Yes 3
No 5
Diagnosed with AIDS
Yes 5
No 3
Taking medication for HIV
Yes 8
Knowledge about the last CD4 count 
Varied experiences of HIV testing during the IME
Participants were asked to describe the HIV testing during the IME. Participants discussed the extent to which they gave informed consent for HIV screening. Four of the participants were not told that the IME would include a mandatory HIV test. Participants stated that neither preHIV test counselling services nor information about the IME process were provided. Participants described feeling desperate to leave their countries and being willing to fulfill any medical requirements, without questioning what was being asked of them.
Five participants knew of their HIV status prior to the IME. One of the participants who first learned they were HIVpositive through the IME process described the news as devastating: Participants received varying types of counselling after learning of their positive HIV diagnosis. One participant was so shocked to hear they were HIV positive, they could not clearly recall the counsel ling they received:
On being positively diagnosed for the first time during the IME, one participant described worrying about the effect on his family and the immigration process for himself and his children:
. 
Disclosure concern 2
Social relationships 1
Self-acceptance 5
Source: Sayles et al. 16 Abbreviations: IHSS, Internalized HIV Stigma Scale. Five participants reported that they did not begin HIV treatment until they had arrived in Canada. One participant was told by the diagnosing panel physician in Botswana that he was "still okay" because his "CD4 count was above 200." A partici pant whose CD4 count was above 200 reported that he was not eligible to access affordable antiretroviral therapy (ART) in Uganda. A friend reassured this partici pant that HIV treatment would be pro vided free of charge in Canada:
This is a country where they have very nice treatment and it will be given to you free, so don't get worried of any thing. You will be taken care of. (P100)
Discussion
Findings from this pilot study reveal important insights into the experiences of SSA immigration applicants living with HIV in a western Canadian province. These findings speak to the intersections between current Canadian immigration policy, includ ing mandatory HIV screening during the IME; adequate and appropriate pre and postHIVtest counselling, including engage ment with the HIV care cascade; HIV related stigma, including internalized HIV stigma among immigration applicants and enacted stigma in the immigration sys tem; and disparities in HIV care cascade engagement.
Most immigration applicants who wish to migrate to and settle in Canada must com plete an IME conducted by a registered panel physician in Canada or overseas.
The IME involves screening and assess ment of physical and mental health; HIV screening is mandatory. The "regulated exceptionalism in the form of mandatory immigration HIV testing policy" 23,p.128 dur ing the IME and the ethical implications of such a public policy have been discussed elsewhere. 23, 24 HIV testing as part of the IME became mandatory in 2002; it remains the only test added to the IME in the past 50 years. 23 21, 26 or have no access to HIV treatment. 21, 26 Although the stated primary purpose of mandatory HIV screening during the IME is to determine public health risk or exces sive demand on the health system, Canada needs to consider the human rights impli cation of conducting mandatory HIV screening during the immigration process. Though some immigration applicants (for example, family class or refugee appli cants) who test positive for HIV may not be assessed as medically inadmissible, 27 others may be.
The IME panel physician should refer all applicants who test positive for HIV dur ing the IME process to appropriate treat ment and care. In our study, not all participants described appropriate care measures during the HIV testing process. They described genuine fear about their HIVpositive status and the impact that a positive diagnosis may have on their immigration application. This fear of liv ing with HIV or starting ART resulted in significant emotional distress at the time of diagnosis, with some participants ideat ing suicide. Participants reported lack of emotional support immediately after receiv ing their positive HIV diagnosis.
Finally, several participants reported delay ing HIV treatment. While HIV treatment guidelines and initiation of ART are com plex, 28 those participating in this study did not describe having indepth discussions on HIV treatment and support options with the IME panel physician. PreHIV test counselling is not time con suming. 31 It includes telling the individual about their rights regarding HIV screening and about the process, potential outcomes and followup care and support. As much as possible, counselling should be in the immigration applicant's language. Current standards for preHIV test counselling include, at a minimum, a conversation with the patient regarding means of HIV transmission and prevention; a descrip tion of the testing procedure and confi dentiality, reporting and record handling; meaning of HIV screening test results, including the possibility of false positive or false negative results; the need to inform anyone at risk of infection if the test is positive; and the need for the patient's consent to undergo testing.
Our findings suggest that participants may not have received adequate or appropriate preHIV test counselling. Also significant is that more than half of the participants reported not being informed that an HIV test was a mandatory part of the IME. From a human rightsbased approach to public health, individuals must be informed and be able to provide consent to HIV testing. 31 Current Canadian IME guidelines indicate that postHIVtest counselling is not man datory for immigration applicants who test negative for HIV 31 but is required for those who test positive. The postHIVtest counselling should include referral to an HIV specialist for counselling, HIV viral load testing, CD4 counts and ART, when indicated. 27, 31 Further, panel physicians are required to complete a form that immigra tion applicants sign, acknowledging com pletion of postHIVtest counselling. 27, 31 Several participants in our study did not receive adequate postHIVtest counsel ling. For example, one participant reported not being told how to seek HIV treatment after the IME process or on arriving in Canada. This participant relied on rela tives in Canada to access HIV specialized care. None of the interviewees recalled signing the form that acknowledged receipt of postHIVtest counselling. This exposes a troublesome disconnection between the IME process and linkage to HIV care and support, particularly given Canada's stated policy commitments to the UNAIDS 90-90-90 treatment target to help end the global AIDS epidemic. 32
People living with HIV in Canada need to be informed of the medicolegal impli cations of HIV transmission without dis closure. 33 The criminalization of HIV nondisclosure is a complex issue. 33 The Supreme Court of Canada "has ruled that people living with HIV have an obligation to disclose their status to a sexual partner before sexual activity that poses a signifi cant risk of serious bodily harm" 33,p.3,34 . In the face of complexity regarding HIV non disclosure laws in Canada, our study find ings show that participants received minimal information about their legal obligation to disclose their HIV status to a sexual partner. In addition, participants reported receiving this information about their legal obligation in varying degrees of detail. This too is of concern from a rights based perspective. If people living with HIV are not aware of the laws of the coun try into which they are settling, they may be at risk for becoming entangled with the Canadian legal system.
The role of the panel physician during the IME has been previously questioned. 23, 24 We propose that the IME panel physician play a key role in engaging immigration applicants in the HIV care cascade during the premigration and migration process; provide information on how the immigra tion applicants could remain engaged in the HIV care cascade once in Canada; and inform the HIVpositive immigration applicant about the medicolegal implica tions of HIV nondisclosure.
Instead of being limited to HIV detection for the purpose of immigration policies, the panel physician could act as an impor tant catalyst to ensure immigration appli cants engage in the HIV care cascade during their migration to and settlement in Canada. The IME panel physician could also make sure that the individual under stands the options for HIV care and sup port during the migration and settlement trajectory. Based on our findings, it was not clear how participants engaged or continued to engage in their HIV care from the time of their diagnosis to the referral to an HIV specialist.
The IHSS data reveal that study partici pants' experiences contributed signifi cantly to internalized stigma associated with selfacceptance. Examining IHSS data alongside participants' shared experi ences raises questions on the relationship between internalized HIV stigma and institutional structures such as policy, clinical practice guidelines for mandatory HIV screening during immigration, health care provider practices and people's social contexts of migration and settlement.
Participants also described a layered effect of internalized HIV stigma and emotional stress: stress related to transnational migration and settlement, that is, the immigration process, and stress associated with receiving a new HIV diagnosis or managing their HIVrelated illness during migration to Canada. The emotional dis tress experienced by participants who receive a positive HIV diagnosis for the first time during the IME was significant. People have reported feeling trauma after receiving a positive HIV diagnosis, and responses to such a diagnosis include shock, disbelief, depression, suicide ide ation and anger. 3538 Participants described worrying and feel ing stressed about how their positive HIV diagnosis would negatively affect their immigration application to Canada. Although refugee applicants cannot be denied admissibility based solely on a positive HIV diagnosis, internalized stigma was evident through the intense fear of depor tation several applicants described. Third, the authors were not able to con duct a genderbased analysis of pilot data to allow examination of patterns of stigma among men, women or people who iden tify as transgender due to the small sam ple size.
Despite these limitations, the findings of this study act as a catalyst to further investigate the experiences of immigration applicants during mandatory HIV screen ing, internalized and enacted stigma dur ing the IME, and how systemic factors can potentially affect health and social ine qualities in immigrants living with HIV in the context of migration to and settlement in Canada. By understanding such social processes, we can develop ways to better support improved health and social out comes of migrants to Canada living with HIV.
Finally, it is important to attend to the psychosocial and mental health needs of all people, including immigrants, living with HIV. Our findings show the critical importance of supporting the wellbeing of SSA immigrants living with HIV in Canada. Many migrants experience signif icant trauma as a result of displacement, armed conflict, violence and human rights violations. 41 Our findings suggest that immi gration applicants may require strengthened psychosocial support given the significant potential effects on mental health and wellbeing that the intersections of past trauma, living with HIV, class and culture can have. Further study is needed to understand the mental health and wellbe ing of immigrants living with HIV across regions in Canada.
Conclusion
Results of this study indicate disparities in the way that mandatory HIV screening is conducted by governmentregistered IME panel physicians located in Canada and overseas. Despite standard HIV screening guidelines for panel physicians, partici pants reported a range of experiences. Key themes that emerged included HIVrelated emotional distress and varied experiences of HIV testing during the IME and incon sistent patterns of linkage to medical care, psychosocial supports and engagement in the HIV care cascade. This warrants fur ther study as immigration applicants' engagement in the HIV care cascade could be compromised by inconsistent HIV test counselling procedures and resultant HIV stigma.
This study contributes to the information on the experiences of SSA immigrants liv ing with HIV in Canada, particularly in western Canada. Availability of HIV care, treatment and support varies across prov inces and territories. It is important to understand the social context of immi grants living with HIV, and how this may influence engagement in the HIV care cas cade. Further study in this population is recommended to examine the intersec tions of current mandatory HIV screening process during the immigration process, migration, settlement, culture, stigma and engagement in the HIV care cascade.
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